# Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

> **NCT00238303** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 103 (actual)

## Conditions studied

- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Recurrent Adult Brain Tumor

## Interventions

- **DRUG:** vorinostat
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00238303
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-07
- **Final completion:** 2010-03
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238303, "Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00238303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*